Article info
Original articles
Clinical science
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study
- Dr W-M Chan, Department of Ophthalmology, Hong Kong Sanatorium & Hospital, 8/F, Li Shu Pui Block, 2 Village Road, Happy Valley, Hong Kong, People’s Republic of China; cwm6373{at}netvigator.com
Citation
Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study
Publication history
- Accepted August 26, 2008
- First published September 18, 2008.
Online issue publication
February 09, 2022
Article Versions
- Previous version (9 February 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group